{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T01:48:40Z","timestamp":1767836920282,"version":"3.49.0"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.ejogrb.2017.06.004","type":"journal-article","created":{"date-parts":[[2017,6,3]],"date-time":"2017-06-03T18:46:23Z","timestamp":1496515583000},"page":"164-168","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Optimal routes of administration, vehicles and timing of progesterone treatment for inhibition of delivery during pregnancy"],"prefix":"10.1016","volume":"216","author":[{"given":"Dajun","family":"Fang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert E.","family":"Garfield","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruben","family":"Kuon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huimin","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejogrb.2017.06.004_bib0005","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0140-6736(08)60074-4","article-title":"Epidemiology and causes of preterm birth","volume":"371","author":"Goldenberg","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.ejogrb.2017.06.004_bib0010","series-title":"Preterm birth: causes, consequences, and prevention","first-page":"398","author":"Behrman","year":"2007"},{"key":"10.1016\/j.ejogrb.2017.06.004_bib0015","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1126\/science.929182","article-title":"Gap junctions: their presence and necessity in myometrium during parturition","volume":"198","author":"Garfield","year":"1977","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.ejogrb.2017.06.004_bib0020","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/0002-9378(81)90270-2","article-title":"Appearance of gap junctions in the myometrium of women during labor","volume":"140","author":"Garfield","year":"1981","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.ejogrb.2017.06.004_bib0025","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0002-9378(16)32279-7","article-title":"Endocrine structural and functional changes in the uterus during premature labor","volume":"142","author":"Garfield","year":"1982","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.ejogrb.2017.06.004_bib0030","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/S0002-9378(87)80315-0","article-title":"Effects of the antiprogesterone RU 486 on preterm birth in the rat","volume":"157","author":"Garfield","year":"1987","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2017.06.004_bib0035","first-page":"436","article-title":"Control of myometrial contractility: role and regulation of gap junctions","volume":"10","author":"Garfield","year":"1988","journal-title":"Oxf Rev Reprod Biol"},{"key":"10.1016\/j.ejogrb.2017.06.004_bib0040","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1001\/archpedi.159.1.58","article-title":"Prepregnancy health status and the risk of preterm delivery","volume":"159","author":"Haas","year":"2005","journal-title":"Arch Pediatr Adolesc Med"},{"key":"10.1016\/j.ejogrb.2017.06.004_bib0045","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1016\/j.ajog.2005.02.015","article-title":"Biochemical markers for the prediction of preterm birth","volume":"192","author":"Goldenberg","year":"2005","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.ejogrb.2017.06.004_bib0050","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1097\/AOG.0b013e31825af2f0","article-title":"ACOG practice bulletin no. 127: management of preterm labor","volume":"119","author":"American College of Obstetricians and Gynecologists","year":"2012","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2017.06.004_bib0055","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.siny.2011.08.001","article-title":"Prevention of preterm birth","volume":"17","author":"Flood","year":"2012","journal-title":"Semin Fetal Neonatal Med"},{"key":"10.1016\/j.ejogrb.2017.06.004_bib0060","series-title":"Born too soon: the global action report on preterm birth","first-page":"1","author":"World health Organization","year":"2012"},{"key":"10.1016\/j.ejogrb.2017.06.004_bib0065","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1067\/mob.2003.41","article-title":"Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: a randomized placebo-controlled double-blind study","volume":"188","author":"Da Fonseca","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2017.06.004_bib0070","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/uog.9017","article-title":"Vaginal progesterone reduces the rate of preterm birth in women with a sonographic short cervix: a multicenter, randomized, double-blind, placebo-controlled trial","volume":"38","author":"Hassan","year":"2011","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2017.06.004_bib0075","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1056\/NEJMoa035140","article-title":"Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate","volume":"348","author":"Meis PJ","year":"2003","journal-title":"N Engl J Med"},{"issue":"455","key":"10.1016\/j.ejogrb.2017.06.004_bib0080","first-page":"e1","article-title":"Pharmacologic actions of progestins to inhibit cervical ripening and prevent delivery depend on their properties, the route of administration, and the vehicle","volume":"202","author":"Kuon","year":"2010","journal-title":"Am J Obstet Gynecol"},{"issue":"455","key":"10.1016\/j.ejogrb.2017.06.004_bib0085","first-page":"e1","article-title":"A novel optical method to assess cervical changes during pregnancy and use to evaluate the effects of progestins on term and preterm labor","volume":"202","author":"Kuon","year":"2010","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2017.06.004_bib0090","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1111\/j.1600-0412.2011.01178.x","article-title":"Progestin treatment for the prevention of preterm birth","volume":"90","author":"Lucovnik","year":"2011","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.ejogrb.2017.06.004_bib0095","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1093\/humupd\/dmi046","article-title":"New Progestagens for contraceptive use","volume":"12","author":"Sitruk-Ware","year":"2006","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.ejogrb.2017.06.004_bib0100","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S0039-128X(00)00190-2","article-title":"Antiproliferative effects of progesterone antagonists and progesterone receptor modulators on the endometrium","volume":"65","author":"Chwalisz","year":"2000","journal-title":"Steroids"},{"key":"10.1016\/j.ejogrb.2017.06.004_bib0105","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.steroids.2003.08.008","article-title":"Conception and pharmacodynamic profile of drospirenone","volume":"68","author":"Elger","year":"2003","journal-title":"Steroids"},{"key":"10.1016\/j.ejogrb.2017.06.004_bib0110","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S0039-128X(00)00178-1","article-title":"Endocrine pharmacological characterization of progesterone antagonists and progesterone receptor modulators with respect to PR-agonistic and antagonistic activity","volume":"65","author":"Elger","year":"2000","journal-title":"Steroids"},{"key":"10.1016\/j.ejogrb.2017.06.004_bib0115","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.steroids.2013.04.003","article-title":"Synthesis and biological evaluation of partially fluorinated antiprogestins and mesoprogestins","volume":"78","author":"Nickisch","year":"2013","journal-title":"Steroids"},{"key":"10.1016\/j.ejogrb.2017.06.004_bib0120","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.steroids.2012.09.010","article-title":"Synthesis and biological Synthesis and biological evaluation of partially fluorinatedantiprogestins and mesoprogestins","volume":"78","author":"Nickisch","year":"2013","journal-title":"Steroids"},{"key":"10.1016\/j.ejogrb.2017.06.004_bib0125","first-page":"403","article-title":"Direct transport of progesterone from vagina to uterus","volume":"95","author":"Cicinelli","year":"2000","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2017.06.004_bib0130","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1749-6632.1997.tb48550.x","article-title":"The first uterine pass effect","volume":"828","author":"De Ziegler","year":"1997","journal-title":"Ann N Y Acad Sci"},{"issue":"5","key":"10.1016\/j.ejogrb.2017.06.004_bib0135","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1002\/uog.5158","article-title":"Progesterone vaginal gel for the reduction of recurrent preterm birth: primary results from a randomized, double-blind, placebo-controlled trial","volume":"30","author":"O'Brien","year":"2007","journal-title":"Ultrasound Obstet Gynecol"}],"container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211517302786?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211517302786?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T05:41:31Z","timestamp":1759556491000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211517302786"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":27,"alternative-id":["S0301211517302786"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2017.06.004","relation":{},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optimal routes of administration, vehicles and timing of progesterone treatment for inhibition of delivery during pregnancy","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2017.06.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier Ireland Ltd.","name":"copyright","label":"Copyright"}]}}